These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34877074)

  • 61. Pembrolizumab and concurrent hypo-fractionated radiotherapy for advanced non-resectable cutaneous squamous cell carcinoma.
    Lavaud J; Blom A; Longvert C; Fort M; Funck-Brentano E; Saiag P
    Eur J Dermatol; 2019 Dec; 29(6):636-640. PubMed ID: 31903954
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
    Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
    Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinoma.
    Litchman GH; Fitzgerald AL; Kurley SJ; Cook RW; Rigel DS
    Curr Med Res Opin; 2020 Aug; 36(8):1295-1300. PubMed ID: 32372702
    [No Abstract]   [Full Text] [Related]  

  • 64. Characterisation of Prognosis and Invasion of Cutaneous Squamous Cell Carcinoma by Podoplanin and E-Cadherin Expression.
    Hesse K; Satzger I; Schacht V; Köther B; Hillen U; Klode J; Schaper K; Gutzmer R
    Dermatology; 2016; 232(5):558-565. PubMed ID: 27875814
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test for Improved Patient Management Decisions and Disease-Related Outcomes when Combined with Current Clinicopathological Risk Factors for Cutaneous Squamous Cell Carcinoma (cSCC): Case Series.
    Au JH; Hooper PB; Fitzgerald AL; Somani AK
    Dermatol Ther (Heidelb); 2022 Feb; 12(2):591-597. PubMed ID: 34951694
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Metastatic Squamous Cell Carcinoma: A Cautionary Tale.
    Shreve C; Shropshire C; Cotter DG
    Cureus; 2020 Oct; 12(10):e10879. PubMed ID: 33178531
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Low incidence of metastasis and recurrence from cutaneous squamous cell carcinoma found in a UK population: Do we need to adjust our thinking on this rare but potentially fatal event?
    Nelson TG; Ashton RE
    J Surg Oncol; 2017 Nov; 116(6):783-788. PubMed ID: 28703911
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The incidence of metastasis from cutaneous squamous cell carcinoma and the impact of its risk factors.
    Brougham ND; Dennett ER; Cameron R; Tan ST
    J Surg Oncol; 2012 Dec; 106(7):811-5. PubMed ID: 22592943
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A prospective evaluation of the clinical, histologic, and therapeutic variables associated with incidental perineural invasion in cutaneous squamous cell carcinoma.
    Campoli M; Brodland DG; Zitelli J
    J Am Acad Dermatol; 2014 Apr; 70(4):630-636. PubMed ID: 24433872
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma.
    Cañueto J; Cardeñoso E; García JL; Santos-Briz Á; Castellanos-Martín A; Fernández-López E; Blanco Gómez A; Pérez-Losada J; Román-Curto C
    Br J Dermatol; 2017 May; 176(5):1279-1287. PubMed ID: 27510450
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Metastatic patterns and treatment options for head and neck cutaneous squamous cell carcinoma (Review).
    Iancu D; Fulga A; Vesa D; Zenovia A; Fulga I; Sarbu MI; Tatu AL
    Mol Clin Oncol; 2024 Jun; 20(6):40. PubMed ID: 38756868
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment approaches in immunosuppressed patients with advanced cutaneous squamous cell carcinoma.
    Willenbrink TJ; Jambusaria-Pahlajani A; Arron S; Seckin D; Harwood CA; Proby CM
    J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():57-60. PubMed ID: 31833603
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Risk factors for positive margins after wide local excision of cutaneous squamous cell carcinoma.
    Stewart TJ; Saunders A
    J Dermatolog Treat; 2018 Nov; 29(7):706-708. PubMed ID: 29448853
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Staging cutaneous squamous cell carcinoma metastases to the parotid gland.
    Czerwonka L; De Santis RJ; Horowitz G; Hong M; Orsini M; Enepekides D; Goldstein DP; Dort J; Higgins K
    Laryngoscope; 2017 Sep; 127(9):2063-2069. PubMed ID: 28295401
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic factors and the role of adjuvant radiation therapy in non-melanoma skin cancer of the head and neck.
    Porceddu SV
    Am Soc Clin Oncol Educ Book; 2015; ():e513-8. PubMed ID: 25993217
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients.
    Metchnikoff C; Mully T; Singer JP; Golden JA; Arron ST
    J Am Acad Dermatol; 2012 Nov; 67(5):829-35. PubMed ID: 22285618
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Risk factors for metastatic cutaneous squamous cell carcinoma: Refinement and replication based on 2 nationwide nested case-control studies.
    Tokez S; Venables ZC; Hollestein LM; Qi H; Bramer EM; Rentroia-Pacheco B; van den Bos RR; Rous B; Leigh IM; Nijsten T; Mooyaart AL; Wakkee M
    J Am Acad Dermatol; 2022 Jul; 87(1):64-71. PubMed ID: 35259451
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Outcomes of recurrent head and neck cutaneous squamous cell carcinoma.
    Dean NR; Sweeny L; Magnuson JS; Carroll WR; Robinson D; Desmond RA; Rosenthal EL
    J Skin Cancer; 2011; 2011():972497. PubMed ID: 21773040
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Parotid metastases of cutaneous squamous cell carcinoma in renal transplant recipients: Case series and literature review.
    Mokos M; Bašić-Jukić N
    Dermatol Ther; 2021 May; 34(3):e14907. PubMed ID: 33619803
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cutaneous Squamous Cell Carcinoma: An Updated Review.
    Jiang R; Fritz M; Que SKT
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.